Skip to main content
. 2012 Sep;53(9):1910–1919. doi: 10.1194/jlr.M027680

Fig. 6.

Fig. 6.

TSA treatment promotes p-ERK1/2 detachment from the CYP46A1 promoter. ChIP was performed using chromatin prepared from SH-SY5Y control cells and cells treated with 250 nM TSA for the indicated time points. After chromatin precipitation with an anti-p-ERK1/2 antibody, the recovered DNA was evaluated by real-time PCR. Results represent means ± SEM of at least three independent experiments and are expressed as a percentage of total input (*P < 0.05).